Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Thompson, William R ^a   Uzer, Gunes ^b   Brobst, Kaitlyn E ^b   Xie, Zhihui ^b   Sen, Buer ^b   Yen, Sherwin S ^b   Styner, Maya ^b   Rubin, Janet ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN2 PROTEIN, MOUSE; BETA CATENIN; DNA BINDING PROTEIN; GLYCOPROTEIN; INIP PROTEIN, HUMAN; SOST PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CELL LINE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; OSTEOCYTE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AXIN PROTEIN; BETA CATENIN; CELL LINE; DNA-BINDING PROTEINS; GLYCOPROTEINS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 84930947623     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11049     Document Type: Article

References (46)

1. Thompson, W. R., Rubin, C. T. & Rubin, J. Mechanical regulation of signaling pathways in bone. Gene 503, 179-193, doi:10.1016/j. gene.2012.04.076 (2012).
2. Xiong, J. et al. Matrix-embedded cells control osteoclast formation. Nature medicine 17, 1235-1241, doi:10.1038/nm.2448 (2011).
3. Bellido, T. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes. J Musculoskelet Neuronal Interact 6, 358-359 (2006).
4. Quarles, L. D. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nature reviews. Endocrinology 8, 276-286, doi:10.1038/nrendo.2011.218 (2012).
5. McClung, M. R. et al. Romosozumab in postmenopausal women with low bone mineral density. The New England journal of medicine 370, 412-420, doi:10.1056/NEJMoa1305224 (2014).
6. Wang, B. et al. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J Bone Miner Res 29, 878-891, doi:10.1002/jbmr.2105 (2014).
7. Poole, K. E. et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. Faseb J 19, 1842-1844, doi:10.1096/fj.05-4221fje (2005).
8. Ubaidus, S. et al. FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling. Journal of electron microscopy 58, 381-392, doi:10.1093/jmicro/dfp032 (2009).
9. Smith, R. C. et al. Circulating alphaKlotho influences phosphate handling by controlling FGF23 production. The Journal of clinical investigation 122, 4710-4715, doi:10.1172/JCI64986 (2012).
10. Zhang, K. et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 26, 4539-4552, doi:10.1128/MCB.02120-05 (2006).
11. Martin, A. et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. Faseb J 25, 2551-2562, doi:10.1096/fj.10-177816 (2011).
12. Tu, X. et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50, 209-217, doi:10.1016/j.bone.2011.10.025 (2012).
13. Robling, A. G., Bellido, T. & Turner, C. H. Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 6, 354 (2006).
14. Gaudio, A. et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. The Journal of clinical endocrinology and metabolism 95, 2248-2253, doi:10.1210/jc.2010-0067 (2010).
15. Spatz, J. M. et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res 28, 865-874, doi:10.1002/jbmr.1807 (2013).
16. Thompson, W. R. et al. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res 26, 618-629, doi:10.1002/jbmr.236 (2011).
17. Uzer, G. et al. Gap junctional communication in osteocytes is amplified by low intensity vibrations in vitro. PloS one 9, e90840, doi:10.1371/journal.pone.0090840 (2014).
18. Thompson, W. R. et al. Association of the alpha(2)delta(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J Bone Miner Res 26, 2125-2139, doi:10.1002/jbmr.437 (2011).
19. Boggs, M. E., Thompson, W. R., Farach-Carson, M. C., Duncan, R. L. & Beebe, T. P. Co-culture of osteocytes and neurons on a unique patterned surface. Biointerphases 6, 200-209, doi:10.1116/1.3664050 (2011).
20. Papanicolaou, S. E., Phipps, R. J., Fyhrie, D. P. & Genetos, D. C. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. Biorheology 46, 389-399, doi:10.3233/BIR-2009-0550 (2009).
21. Woo, S. M., Rosser, J., Dusevich, V., Kalajzic, I. & Bonewald, L. F. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res 26, 2634-2646, doi:10.1002/jbmr.465 (2011).
22. Cohen-Kfir, E. et al. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 152, 4514-4524, doi:10.1210/en.2011-1128 (2011).
23. Zhu, D., Mackenzie, N. C., Millan, J. L., Farquharson, C. & MacRae, V. E. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PloS one 6, e19595, doi:10.1371/journal.pone.0019595 (2011).
24. Case, N. et al. Mechanical activation of beta-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 28, 1531-1538, doi:10.1002/jor.21156 (2010).
25. Peister, A. et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103, 1662-1668, doi:10.1182/blood-2003-09-3070 (2004).
26. Thompson, W. R. et al. Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells. Stem cells 31, 2528-2537, doi:10.1002/stem.1476 (2013).
27. Sen, B. et al. mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells. J Bone Miner Res 29, 78-89, doi:10.1002/jbmr.2031 (2014).
28. Price, C., Zhou, X., Li, W. & Wang, L. Real-time measurement of solute transport within the lacunar-canalicular system of mechanically loaded bone: direct evidence for load-induced fluid flow. J Bone Miner Res 26, 277-285, doi:10.1002/jbmr.211 (2011).
29. Tanaka-Kamioka, K., Kamioka, H., Ris, H. & Lim, S. S. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res 13, 1555-1568, doi:10.1359/jbmr.1998.13.10.1555 (1998).
30. O'Brien, C. A. et al. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PloS one 3, e2942, doi:10.1371/journal.pone.0002942 (2008).
31. Uzer, G., Pongkitwitoon, S., Ete Chan, M. & Judex, S. Vibration induced osteogenic commitment of mesenchymal stem cells is enhanced by cytoskeletal remodeling but not fluid shear. Journal of biomechanics 46, 2296-2302, doi:10.1016/j.jbiomech.2013.06.008 (2013).
32. Robling, A. G. et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283, 5866-5875, doi:10.1074/jbc.M705092200 (2008).
33. Bodine, P. V. & Komm, B. S. Wnt signaling and osteoblastogenesis. Reviews in endocrine & metabolic disorders 7, 33-39, doi:10.1007/s11154-006-9002-4 (2006).
34. Gortazar, A. R., Martin-Millan, M., Bravo, B., Plotkin, L. I. & Bellido, T. Crosstalk between caveolin-1/extracellular signal-regulated kinase (ERK) and beta-catenin survival pathways in osteocyte mechanotransduction. J Biol Chem 288, 8168-8175, doi:10.1074/jbc.M112.437921 (2013).
35. Honma, M., Ikebuchi, Y., Kariya, Y. & Suzuki, H. Regulatory mechanisms of RANKL presentation to osteoclast precursors. Current osteoporosis reports 12, 115-120, doi:10.1007/s11914-014-0189-0 (2014).
36. Thomas, G. P., Baker, S. U., Eisman, J. A. & Gardiner, E. M. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. The Journal of endocrinology 170, 451-460 (2001).
37. Tang, S. Y., Herber, R. P., Ho, S. P. & Alliston, T. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance. J Bone Miner Res 27, 1936-1950, doi:10.1002/jbmr.1646 (2012).
38. Sharma, D. et al. Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency. Bone 51, 488-497, doi:10.1016/j.bone.2012.05.014 (2012).
39. Bellido, T. et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146, 4577-4583, doi:10.1210/en.2005-0239 (2005).
40. Ben-Awadh, A. N. et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology, en20141046, doi:10.1210/en.2014-1046 (2014).
41. Rubin, J. et al. IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. The Journal of clinical endocrinology and metabolism 87, 4273-4279, doi:10.1210/jc.2002-020656 (2002).
42. Paschalis, E. P., Burr, D. B., Mendelsohn, R., Hock, J. M. & Boskey, A. L. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months. J Bone Miner Res 18, 769-775, doi:10.1359/jbmr.2003.18.4.769 (2003).
43. St John, H. C. et al. The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin d3 hormone. Molecular endocrinology 28, 1150-1165, doi:10.1210/me.2014-1091 (2014).
44. You, L., Cowin, S. C., Schaffler, M. B. & Weinbaum, S. A model for strain amplification in the actin cytoskeleton of osteocytes due to fluid drag on pericellular matrix. Journal of biomechanics 34, 1375-1386 (2001).
45. Niziolek, P. J. et al. High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes. Bone 49, 1010-1019, doi:10.1016/j.bone.2011.07.034 (2011).
46. Thompson, W. R., Yen, S. S. & Rubin, J. Vibration therapy: clinical applications in bone. Current opinion in endocrinology, diabetes, and obesity 21, 447-453, doi:10.1097/MED.0000000000000111 (2014).